Trial Profile
A randomised, multi-centre, open-label study to evaluate the efficacy of VANIQA with laser treatment versus laser treatment alone in female subjects with excessive facial hair (facial hirsutism).
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 21 Jun 2011
Price :
$35
*
At a glance
- Drugs Eflornithine (Primary)
- Indications Hirsutism
- Focus Therapeutic Use
- Sponsors Shire Pharmaceutical Development
- 21 Jun 2011 New trial record